Safety Science Research Laboratories, Kao Corporation, 2606 Akabane, Ichikai-Machi, Haga-Gun, Tochigi 321-3497, Japan.
Toxicol In Vitro. 2013 Mar;27(2):609-18. doi: 10.1016/j.tiv.2012.11.006. Epub 2012 Nov 10.
Recent changes in regulatory restrictions and social views against animal testing have accelerated development of reliable alternative tests for predicting skin sensitizing potential and potency of many chemicals. Lately, a test battery integrated with different in vitro tests has been suggested as a better approach than just one in vitro test for replacing animal tests. In this study, we created a dataset of 101 test chemicals with LLNA, human cell line activation test (h-CLAT), direct peptide reactivity assay (DPRA) and in silico prediction system. The results of these tests were converted into scores of 0-2 and the sum of individual scores provided the accuracy of 85% and 71% for the potential and potency prediction, compared with LLNA. Likewise, the straightforward tiered system of h-CLAT and DPRA provided the accuracy of 86% and 73%. Additionally, the tiered system showed a higher sensitivity (96%) compared with h-CLAT alone, indicating that sensitizers would be detected with higher reliability in the tiered system. Our data not only demonstrates that h-CLAT can be part of a test battery with other methods but also supports the practical utility of a tiered system when h-CLAT and DPRA are the first screening methods for skin sensitization.
最近,监管限制和社会对动物试验的看法发生了变化,这加速了开发可靠的替代试验方法的进程,以预测许多化学物质的皮肤致敏潜力和效力。最近,有人建议采用整合不同体外试验的试验组合,作为替代动物试验的一种更好方法,而不是仅使用一种体外试验。在这项研究中,我们创建了一个包含 101 种测试化学品的数据集,包括局部淋巴结试验(LLNA)、人细胞系激活试验(h-CLAT)、直接肽反应性测定(DPRA)和基于计算的预测系统。将这些试验的结果转换为 0-2 的分数,个体分数的总和为潜在和效力预测提供了 85%和 71%的准确性,与 LLNA 相比。同样,h-CLAT 和 DPRA 的简单分层系统提供了 86%和 73%的准确性。此外,分层系统的灵敏度(96%)高于 h-CLAT 单独使用时的灵敏度,这表明在分层系统中,致敏剂的检测可靠性更高。我们的数据不仅表明 h-CLAT 可以成为与其他方法相结合的试验组合的一部分,而且还支持在 h-CLAT 和 DPRA 作为皮肤致敏的初始筛选方法时使用分层系统的实际效用。